Hospital and community pharmacists working together to make medication changes safer at discharge
Enhanced Collaboration Between Hospital and Community Pharmacists to Improve the Hospital Discharge Process
NA · Pharmacie des Hopitaux de l'Est Lemanique · NCT06902779
This will test whether extra collaboration between the hospital pharmacist and your local pharmacist reduces medication problems for adults taking seven or more medicines when they leave the hospital.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Pharmacie des Hopitaux de l'Est Lemanique (other) |
| Locations | 1 site (Rennaz, Canton of Vaud) |
| Trial ID | NCT06902779 on ClinicalTrials.gov |
What this trial studies
This interventional project implements enhanced collaboration between a hospital pharmacist and the patient’s community pharmacist at the time of hospital discharge. Adults admitted to the internal medicine ward for more than 48 hours who are taking seven or more medications and are being discharged home are enrolled. The hospital pharmacist supports medication management and communicates detailed prescription and clinical information to the community pharmacist, and investigators compare the number of drug-related problems encountered with discharge prescriptions versus usual care. The main measured outcome is the number of drug-related problems identified by community pharmacists after discharge.
Who should consider this trial
Good fit: Ideal candidates are adults admitted to the internal medicine ward for over 48 hours, prescribed seven or more medications at screening, discharged to home, and able to give informed consent.
Not a fit: Patients discharged to another hospital, nursing home, or rehabilitation clinic, those taking fewer than seven medications, or those whose community pharmacy refuses to participate are unlikely to benefit.
Why it matters
Potential benefit: If successful, this approach could reduce medication errors and improve safety for patients managing many drugs after leaving hospital.
How similar studies have performed: Previous studies of pharmacist-led discharge communication and transitional-care pharmacist interventions have generally shown reductions in medication-related problems and readmissions, though results vary by program and setting.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients admitted to the internal medicine ward for more than 48 hours * Patients prescribed seven or more drugs at the time of screening * Patients discharged to home * Patients able to give informed consent as documented by signature Exclusion Criteria: * Patient discharged to another hospital, nursing home or rehabilitation clinic * Refusal of the community pharmacy to participate * Inability to sign consent and follow the procedures of the study, due to language problems, psychological disorders, dementia, alterations of consciousness and lack of judgement
Where this trial is running
Rennaz, Canton of Vaud
- Hôpital Riviera-Chablais, Vaud-Valais — Rennaz, Canton of Vaud, Switzerland (RECRUITING)
Study contacts
- Study coordinator: Paul Garin, PharmD
- Email: paul.garin@phel.ch
- Phone: +41 79 534 21 36
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Polypharmacy, transition of care, pharmacists, hospital discharge, collaboration